全文获取类型
收费全文 | 149篇 |
免费 | 5篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2021年 | 4篇 |
2019年 | 1篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 5篇 |
2014年 | 4篇 |
2013年 | 6篇 |
2012年 | 7篇 |
2011年 | 11篇 |
2010年 | 4篇 |
2009年 | 2篇 |
2008年 | 6篇 |
2007年 | 2篇 |
2006年 | 8篇 |
2005年 | 6篇 |
2004年 | 5篇 |
2003年 | 3篇 |
2002年 | 4篇 |
2001年 | 8篇 |
2000年 | 4篇 |
1999年 | 5篇 |
1998年 | 3篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1968年 | 1篇 |
1940年 | 1篇 |
1929年 | 1篇 |
排序方式: 共有154条查询结果,搜索用时 406 毫秒
81.
Pablo Hofbauer Stefan M. Jahnel Nora Papai Magdalena Giesshammer Alison Deyett Clara Schmidt Mirjam Penc Katherina Tavernini Nastasja Grdseloff Christy Meledeth Lavinia Ceci Ginistrelli Claudia Ctortecka Šejla Šalic Maria Novatchkova Sasha Mendjan 《Cell》2021,184(12):3299-3317.e22
- Download : Download high-res image (298KB)
- Download : Download full-size image
82.
A note on evolutionary stable strategies and game dynamics 总被引:4,自引:0,他引:4
83.
Franz?Josef?Gassner Lukas?Weiss Roland?Geisberger Josefina?Pi?ón?Hofbauer Alexander?Egle Tanja?Nicole?Hartmann Richard?GreilEmail author Inge?Tinhofer 《Cancer immunology, immunotherapy : CII》2011,60(1):75-85
The combination of cytotoxic treatment with strategies for immune activation represents an attractive strategy for tumour
therapy. Following reduction of high tumour burden by effective cytotoxic agents, two major immune-stimulating approaches
are being pursued. First, innate immunity can be activated by monoclonal antibodies triggering antibody-dependent cellular
cytotoxicity. Second, tumour-specific T cell responses can be generated by immunization of patients with peptides derived
from tumour antigens and infused in soluble form or loaded onto dendritic cells. The choice of cytotoxic agents for such combinatory
regimens is crucial since most substances such as fludarabine are considered immunosuppressive while others such as cyclophosphamide
can have immunostimulatory activity. We tested in this study whether fludarabine and/or cyclophosphamide, which represent
a very effective treatment regimen for chronic lymphocytic leukaemia, would interfere with a therapeutic strategy of T cell
activation. Analysis of peripheral blood samples from patients prior and during fludarabine/cyclophosphamide therapy revealed
rapid and sustained reduction of tumour cells but also of CD4+ and CD8+ T cells. This correlated with a significant cytotoxic activity of fludarabine/cyclophosphamide on T cells in vitro. Unexpectedly,
T cells surviving fludarabine/cyclophosphamide treatment in vitro had a more mature phenotype, while fludarabine-treated T
cells were significantly more responsive to mitogenic stimulation than their untreated counterparts and showed a shift towards
TH1 cytokine secretion. In conclusion, fludarabine/cyclophosphamide therapy though inducing significant and relevant T cell
depletion seems to generate a micromilieu suitable for subsequent T cell activation. 相似文献
84.
Thiele S Rauner M Goettsch C Rachner TD Benad P Fuessel S Erdmann K Hamann C Baretton GB Wirth MP Jakob F Hofbauer LC 《Journal of cellular biochemistry》2011,112(6):1593-1600
Skeletal metastases represent a frequent complication in patients with advanced prostate cancer (PCa) and often require bisphosphonate treatment to limit skeletal‐related events. Metastasized PCa cells disturb bone remodeling. Since the WNT signaling pathway regulates bone remodeling and has been implicated in tumor progression and osteomimicry, we analyzed the WNT profile of primary PCa tissues and PCa cell lines and assessed its regulation by bisphosphonates. Prostate tissue (n = 18) was obtained from patients with benign prostate hyperplasia (BPH) and PCa patients with different disease stages. Serum samples were collected from 62 patients. Skeletal metastases were present in 17 patients of whom 6 had been treated with zoledronic acid. The WNT profile and its regulation by bisphoshonates were analyzed in tissue RNA extracts and serum samples as well as in osteotropic (PC3) and non‐osteotropic (DU145, LNCaP) PCa cell lines. Several members of the WNT pathway, including WNT5A, FZD5, and DKK1 were highly up‐regulated in PCa tissue from patients with advanced PCa. Interestingly, osteotropic cells showed a distinct WNT profile compared to non‐osteotropic cells. While WNT5A, FZD5, and DKK1 were highly expressed in PC3 cells, WNT1 and SFRP1 mRNA levels were higher in DU145 cells. Moreover, zoledronic acid down‐regulated mRNA levels of WNT5A (?34%), FZD5 (?60%), and DKK1 (?46%) in PC3 cells. Interestingly, patients with skeletal metastases who received zoledronic acid had twofold higher DKK1 serum levels compared to bisphosphonate‐naive patients. The WNT signaling pathway is up‐regulated in advanced PCa, differentially expressed in osteotropic versus non‐osteotropic cells, and is regulated by zoledronic acid. J. Cell. Biochem. 112: 1593–1600, 2011. © 2011 Wiley‐Liss, Inc. 相似文献
85.
Michael Schoppet Mary M. Kavurma Lorenz C. Hofbauer Catherine M. Shanahan 《Biochemical and biophysical research communications》2011,(1):741
Osteoprotegerin (OPG), a member of the TNF receptor superfamily, was initially found to modulate bone mass by blocking osteoclast maturation and function. Rodent models have also revealed a role for OPG as an inhibitor of vascular calcification. However, the precise mode of how OPG blocks mineralization is unclear. In this study, OPG was found in an in vitro assay to significantly inhibit calcification of vascular smooth muscle cells (VSMC) induced by high calcium/phosphate (Ca/P) treatment (p = 0.0063), although this effect was blunted at high OPG concentrations. By confocal microscopy, OPG was detected in VSMC in the Golgi, the same localization seen in osteoblasts, which express OPG in bone. Treatment of VSMC by minerals (Ca, P, or both) induced OPG mRNA expression as assessed by real-time quantitative PCR, and VSMC derived from atherosclerotic plaque material also exhibited higher OPG expression as compared to control cells (p < 0.05). Furthermore, OPG was detected by Western blotting in matrix vesicles (MV), nanoparticles that are released by VSMC with the capacity to nucleate mineral. In atherosclerotic arteries, OPG colocalized immunohistochemically with annexin VI, a calcium-dependent membrane and phospholipid binding protein found in MV. Thus, the calcification inhibitor OPG is contained in crystallizing MV and has a biphasic effect on VSMC: physiologic concentrations inhibit calcification, whereas high concentrations commonly seen in patients with vascular disease have no effect. Like other calcification inhibitors, OPG may be specifically loaded into these nanoparticles to be deposited at remote sites, where it acts to inhibit calcification. 相似文献
86.
Nemeth K Schoppet M Al-Fakhri N Helas S Jessberger R Hofbauer LC Goettsch C 《Journal of immunology (Baltimore, Md. : 1950)》2011,186(1):13-18
The term osteoimmunology is coined for molecular and cellular cross talk between the skeletal and immune system. Immunomodulatory signals have long been implicated as key regulators of bone metabolism. Recently, osteoclast-associated receptor (OSCAR), an IgG-like receptor, has been identified as an important osteoimmunological mediator. OSCAR expression in bone is highly conserved across different species, and the molecule is an important costimulatory receptor for osteoclast differentiation through activation of NFATc1. In humans, OSCAR is expressed by macrophages, monocytes, and monocyte-derived dendritic cells and modulates the response of the innate and adaptive immune systems by promoting cell activation and maturation, Ag presentation, and proinflammatory circuits. Human studies indicate that OSCAR may contribute to the pathogenesis and severity of osteoporosis and rheumatoid arthritis. In this paper, we review the structure-function relationship, expression pattern, and physiological role of OSCAR in osteoimmunology and summarize its potential implications for human diseases. 相似文献
87.
Konstantin A. Krychtiuk Stefan P. Kastl Stefan Pfaffenberger Max Lenz Sebastian L. Hofbauer Anna Wonnerth Lorenz Koller Katharina M. Katsaros Thomas Pongratz Georg Goliasch Alexander Niessner Ludovit Gaspar Kurt Huber Gerald Maurer Elisabeth Dostal Johann Wojta Stanislav Oravec Walter S. Speidl 《PloS one》2015,10(4)
Objective
Atherosclerosis is considered to be an inflammatory disease in which monocytes and monocyte-derived macrophages play a key role. Circulating monocytes can be divided into three distinct subtypes, namely in classical monocytes (CM; CD14++CD16-), intermediate monocytes (IM; CD14++CD16+) and non-classical monocytes (NCM; CD14+CD16++). Low density lipoprotein particles are heterogeneous in size and density, with small, dense LDL (sdLDL) crucially implicated in atherogenesis. The aim of this study was to examine whether monocyte subsets are associated with sdLDL serum levels.Methods
We included 90 patients with angiographically documented stable coronary artery disease and determined monocyte subtypes by flow cytometry. sdLDL was measured by an electrophoresis method on polyacrylamide gel.Results
Patients with sdLDL levels in the highest tertile (sdLDL≥4mg/dL;T3) showed the highest levels of pro-inflammatory NCM (15.2±7% vs. 11.4±6% and 10.9±4%, respectively; p<0.01) when compared with patients in the middle (sdLDL=2-3mg/dL;T2) and lowest tertile (sdLDL=0-1mg/dL;T1). Furthermore, patients in the highest sdLDL tertile showed lower CM levels than patients in the middle and lowest tertile (79.2±8% vs. 83.9±7% and 82.7±5%; p<0.01 for T3 vs. T2+T1). Levels of IM were not related to sdLDL levels (5.6±4% vs. 4.6±3% vs. 6.4±3% for T3, T2 and T1, respectively). In contrast to monocyte subset distribution, levels of circulating pro- and anti-inflammatory markers were not associated with sdLDL levels.Conclusion
The atherogenic lipoprotein fraction sdLDL is associated with an increase of NCM and a decrease of CM. This could be a new link between lipid metabolism dysregulation, innate immunity and atherosclerosis. 相似文献88.
Martina Paumann-Page Paul G. Furtmüller Stefan Hofbauer Louise N. Paton Christian Obinger Anthony J. Kettle 《Archives of biochemistry and biophysics》2013
Human myeloperoxidase (MPO) uses hydrogen peroxide generated by the oxidative burst of neutrophils to produce an array of antimicrobial oxidants. During this process MPO is irreversibly inactivated. This study focused on the unknown role of hydrogen peroxide in this process. When treated with low concentrations of H2O2 in the absence of reducing substrates, there was a rapid loss of up to 35% of its peroxidase activity. Inactivation is proposed to occur via oxidation reactions of Compound I with the prosthetic group or amino acid residues. At higher concentrations hydrogen peroxide acts as a suicide substrate with a rate constant of inactivation of 3.9 × 10−3 s−1. Treatment of MPO with high H2O2 concentrations resulted in complete inactivation, Compound III formation, destruction of the heme groups, release of their iron, and detachment of the small polypeptide chain of MPO. Ten of the protein’s methionine residues were oxidized and the thermal stability of the protein decreased. Inactivation by high concentrations of H2O2 is proposed to occur via the generation of reactive oxidants when H2O2 reacts with Compound III. These mechanisms of inactivation may occur inside neutrophil phagosomes when reducing substrates for MPO become limiting and could be exploited when designing pharmacological inhibitors. 相似文献
89.
Pallauf A Schirpenbach C Zwermann O Fischer E Morak M Holinski-Feder E Hofbauer L Beuschlein F Reincke M 《Hormones et métabolisme》2012,44(3):215-220
Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension. To date 3 forms of familial hyperaldosteronism (FH) have been described accounting for a small percentage of all PA cases. In Germany, the prevalence of FH is currently unknown. Our aim was to determine the prevalence of familiarity in a large cohort of patients with PA. A total of 166 patients with apparently sporadic PA in Munich were investigated. FH types I, II, and III were identified using established clinical, biochemical, and molecular criteria. Among the 166 patients with PA, 2 patients (1.2%) reported a family history suggestive of FH. None of the 166 patients showed clinical, endocrine, or genetic evidence of FH type I. The 2 families had characteristic features of FH type II. Family A had 3 subjects affected out of 11 evaluated family members. Family B had 3 out of 4. Bilateral adrenal hyperplasia and unilateral adrenal adenoma were found within the same family. FH type I and FH type III are rare in Germany. With a prevalence of 1.2%, FH type II seems to be more common in apparently sporadic PA than had been assumed so far. 相似文献
90.
James H. Dickson Wolfgang Hofbauer Ronald Porley Alexandra Schmidl Werner Kofler Klaus Oeggl 《Vegetation History and Archaeobotany》2009,18(1):13-22
Six different mosses have been recognised in samples taken from the intestinal contents of the 5,200-year-old Iceman from the Eastern Alps. Four of the species are important in understanding the lifestyle of the man and/or bear on the events during the last few days of his life: Anomodon viticulosus, Hymenostylium recurvirostrum, Neckera complanata and Sphagnum imbricatum. The past and present chorology and habitats of the Hymenostylium are discussed in detail, as is the ethnobotany of the Sphagnum concerning both the Iceman and Kwäday Dän Ts’ìnchí, the first ancient glacier body from North America. 相似文献